Screener/Healthcare/Biotechnology

RLMD

Relmada Therapeutics, Inc.NASDAQ
$6.01+0.17 (+2.90%)
Small CapUnder $10Healthcare
$0.24
$7.51
$5.68
$6.21
EPS (TTM)$-1.80
P/E Ratio—
Dividend Yield—
Market Cap$532.1M
Volume818K
Prev Close$5.86
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$0-$10.1M$-0.30——
Q2 '25$0-$9.9M$-0.30——
Q1 '25$0-$17.6M$-0.58——
Q4 '24$0-$18.7M$-0.62——
Q3 '24$0-$21.7M$-0.72——
Q2 '24$0-$17.8M$-0.59——
Q1 '24$0-$21.8M$-0.72——
Q4 '23$1.3M-$25.2M$0.76—-1998.5%
Get Your Daily Market Recap